Počet záznamov: 1
tromboxány
SYS d013931 LBL 00000cz--a2200000n--4500 005 20250606213018.3 008 920523|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D10.251.355.255.100.825 065 $a D10.251.355.310.166.971 066 $a 01 $c 03 150 $a tromboxány $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Thromboxane $2 eng 450 $w v $a TX $2 slo 450 $w v $a tromboxán $2 slo 450 $w v $a TX $2 slo 550 $7 sllk_us_auth*d017482 $Y Receptors, Thromboxane $w p $a receptory tromboxánové 665 $a 78 $2 eng 665 $a Fatty Acids, Unsaturated (1973-1974) $2 eng 665 $a Hydroxy Acids (1975-1977) $2 eng 665 $a Pyrans (1966-1977) $2 eng 680 9-
$i Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. $2 eng 750 -2
$a Thromboxanes $2 eng 980 $x M
Počet záznamov: 1